In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to discuss recent news and updates. Later, Dr. Pritt welcomes Chris Garcia, M.D., Mayo Clinic Laboratories’ chief digital innovation officer, to explore digital advances in clinical diagnostics.

• AI systems for healthcare guidance (00:36): Learn how patients and consumers are using AI tools to better understand their health information.
• Diagnostic’s digital innovation journey (07:43): Explore the evolution of digital advances, their impact on care today, and what lies ahead.
• Guidance for selecting new tools (20:51): Gain practical guidance on selecting new digital tools in the laboratory.

Note: Information in this post was accurate at the time of its posting.

Resources

• From Intake to Interpretation: How AI Assists Lab Teams Today
• Making the Promise of AI a Reality in Laboratory Medicine and Pathology

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to share industry updates and Mayo Clinic’s test development success in 2025. Later, Dr. Pritt welcomes Janelle Santos, M.D., a maternal-fetal medicine specialist at Mayo Clinic, to discuss how she uses a preeclampsia test to care for her patients.

• Public policy insights for 2026 (00:34): Dr. Bill Morice shares insights on reimbursement and AI-related policy developments following an association meeting in Washington, D.C.
• An unprecedented year for test development (04:45): Discover how Mayo Clinic’s record year for test development delivers value to Mayo Clinic’s patients and Mayo Clinic Laboratories’ clients.
• Novel preeclampsia testing (08:13): Learn how new clinical testing helps physicians improve outcomes for women at risk for preeclampsia and their babies.

Note: Information in this post was accurate at the time of its posting.

Resources

• 4 steps to establishing a new approach to innovation
• Innovation beyond the bench: Translating science into better diagnostics and outcomes
• Preeclampsia: Empowering confident decision-making through preeclampsia risk assessment
• Assay stratifies pregnant women's preeclampsia risk: Joshua Bornhorst, Ph.D.
• Preeclampsia sFlt-1/PIGF Ratio, Serum (Mayo ID: PERA)

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, to explore recent examples of diagnostic innovations that are improving patient care. Dr. Pritt also welcomes Matthew Schultz, Ph.D., a clinical biomedical geneticist at Mayo Clinic, to discuss how a novel test is delivering answers for patients with a recently identified peripheral neuropathy.

• Transplant testing innovations (00:57): Discover how advances in clinical diagnostics are improving transplant outcomes at Mayo Clinic.
• Advances reshaping rheumatoid arthritis diagnostics (06:06): Learn how early-stage research and emerging tools are reshaping care for patients with rheumatoid arthritis.
• New test for peripheral neuropathy (08:18): A novel test created to support care for patients with a recently identified condition now supporting research to advance care.

Note: Information in this post was accurate at the time of its posting.

Resources

• Rewriting the future of rheumatoid arthritis: How early detection is transforming prevention
• Cultivating a comprehensive test menu for organ transplant patients
• Screening test for sorbitol dehydrogenase deficiency-related neuropathy (SORD)
• Innovative SORD test provides clarity for two young patients: Justin Fugelsang and Zach Pedowitz